• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. PERCEVAL SUTURELESS AORTIC VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. PERCEVAL SUTURELESS AORTIC VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVS23
Device Problems Gradient Increase (1270); Material Too Rigid or Stiff (1544)
Patient Problems Aortic Insufficiency (1715); Aortic Valve Stenosis (1717); Calcium Deposits/Calcification (1758); Cardiac Arrest (1762); Cardiogenic Shock (2262)
Event Date 04/24/2015
Event Type  Injury  
Manufacturer Narrative
Device not explanted.
 
Event Description
The manufacturer received information about this event through the (b)(6) study database.On (b)(6) 2012, a (b)(6) years old male patient received a perceval pvs23 in aortic position.The procedure was performed in mini-thoracotomy and no concomitant procedures occurred.At discharge, the echo showed a mean gradient of 15mmhg and no central/perivalvular leaks.On (b)(6) 2015, a structural valve deterioration was identified.It is reported that the leaflet appeared stiffened (calcified), resulting in a steno-insufficiency of the device.The patient was symptomatic.About one month later, on (b)(6) 2015, the patient had a cardiogenic shock followed by cardiac arrest.On (b)(6) 2015, a re-intervention occurred due to structural valve deterioration of the device.A valve-in-valve procedure was performed.Prior to the event, the last available information on the device functionality is in (b)(6) 2013; the echo performed showed a mean gradient of 14mmhg and no central/perivalvular leaks.
 
Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.
 
Manufacturer Narrative
Since the device was not explanted, no further device analysis can be performed.As such, the root cause of the event cannot be determined at this time.It could be possible, as also confirmed by the site, that the patient's renal insufficiency contributed to the reported structural valve deterioration.However, this cannot be confirmed due to the limited investigation performed, and the root cause remains ultimately unknown.It should be noted that structural valve deterioration is a known inherent risk associated with cardiac valve replacement with a bioprosthesis, and is listed among the potential adverse events in the perceval instructions for use.
 
Event Description
The manufacturer received information about this event through the sure avr study database.On (b)(6) 2012, a 71 years old male patient received a perceval pvs23 in aortic position.The procedure was performed in mini-thoracotomy and no concomitant procedures occurred.At discharge, the echo showed a mean gradient of 15mmhg and no central/perivalvular leaks.A good valve functionality was also observed in nov 2013 (mean gradient of 14mmhg, no leaks) on 24 apr 2015, a structural valve deterioration was identified.It is reported that the leaflet appeared stiffened (calcified), resulting in a steno-insufficiency of the device.The patient was symptomatic.About one month later, on (b)(6) 2015, the patient had a cardiogenic shock followed by cardiac arrest.On (b)(6) 2015, a re-intervention occurred due to structural valve deterioration of the device.A valve-in-valve procedure was performed, without any complication.The patient moved to another hospital in good conditions.The site reported that the may have been a relationship between the patient's renal insufficiency and the reported structural valve deterioration.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia, vercelli
MDR Report Key8392867
MDR Text Key137929810
Report Number3005687633-2019-00155
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup,Followup
Report Date 04/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/29/2014
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/08/2019
Initial Date FDA Received03/05/2019
Supplement Dates Manufacturer Received03/15/2019
04/17/2019
Supplement Dates FDA Received04/10/2019
04/18/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
Patient Weight67
-
-